de Lacerda Tonielli Cristina Sousa, Costa-Silva Bruno, Giudice Fernanda Salgueiredo, Dias Marcos Vinicios Salles, de Oliveira Gabriela Pintar, Teixeira Bianca Luise, Dos Santos Tiago Goss, Martins Vilma Regina
International Research Center, A.C.Camargo Cancer Center, Rua Taguá, 440 - Liberdade, São Paulo, SP, 01508-010, Brazil.
Department of Biochemistry, Institute of Chemistry, University of São Paulo (USP), Av. Prof. Lineu Prestes, 748 - Cidade Universitária, São Paulo, SP, 05508-000, Brazil.
Clin Exp Metastasis. 2016 Jun;33(5):441-51. doi: 10.1007/s10585-016-9788-8. Epub 2016 Apr 25.
Colorectal cancer (CRC) is one of the most frequently diagnosed malignancies. The generation of conventional treatments has improved, but approximately 50 % of patients with CRC who undergo potentially curative surgery ultimately relapse and die, usually as a consequence of metastatic disease. Our previous findings showed that engagement of the cellular prion protein (PrP(C)) to its ligand HSP70/90 heat shock organizing protein (HOP) induces proliferation of glioblastomas. In addition, PrP(C) has been described as an important modulator of colorectal tumor growth. Here, we investigated the biological relevance of the PrP(C)-HOP interaction in CRC cells. We demonstrate that HOP induced the migration and invasion of CRC cell lines in a PrP(C)-dependent manner and that phosphorylation of the ERK1/2 pathway is a downstream mediator of these effects. Additionally, we show that a HOP peptide with the ability to bind PrP(C) and abolish the PrP(C)-HOP interaction inhibited the migration and invasion of CRC cells. Together, these data indicate that the disruption of the PrP(C)-HOP complex could be a potential therapeutic target for modulating the migratory and invasive cellular properties that lead to metastatic CRC.
结直肠癌(CRC)是最常被诊断出的恶性肿瘤之一。传统治疗方法虽有所改进,但约50%接受了潜在根治性手术的CRC患者最终会复发并死亡,通常是转移性疾病所致。我们之前的研究结果表明,细胞朊蛋白(PrP(C))与其配体HSP70/90热休克组织蛋白(HOP)结合会诱导胶质母细胞瘤增殖。此外,PrP(C)已被描述为结直肠肿瘤生长的重要调节因子。在此,我们研究了CRC细胞中PrP(C)-HOP相互作用的生物学相关性。我们证明HOP以PrP(C)依赖的方式诱导CRC细胞系的迁移和侵袭,并且ERK1/2通路的磷酸化是这些效应的下游介质。此外,我们表明一种具有结合PrP(C)并消除PrP(C)-HOP相互作用能力的HOP肽可抑制CRC细胞的迁移和侵袭。总之,这些数据表明PrP(C)-HOP复合物的破坏可能是调节导致转移性CRC的迁移和侵袭细胞特性的潜在治疗靶点。